Tenth Circuit Opinion in PCMA v. Mulready
In an unfortunate – and arguably errant – legal development, the United States Tenth Circuit Court of Appeals on Tuesday issued an unfavorable decision.
Pharmacy Organizations Blast Tenth Circuit Decision Invalidating an Oklahoma Law Regulating PBMs Ruling creates a split in the federal courts that could lead to the Supreme Court
Ruling creates a split in the federal courts that could lead to the Supreme Court.
“Innovation Abounds” with Retailer-Supplier Collaboration at NACDS Total Store Expo, as Leaders Mark NACDS’ 90th Year NACDS Chair Mike Wysong: “The NACDS Total Store Expo continues to reimagine ‘what could be’ and to foster innovation by bringing together the right people, at the right time, in the right setting.”
NACDS leadership welcomed NACDS-member retailers and suppliers to San Diego, CA, for the NACDS Total Store Expo — the third conference in the 2023 calendar of NACDS events celebrating the Association’s 90th Anniversary Year.
NACDS Applauds Sen. Crapo’s Bipartisan Approach to Reducing Patients’ Drug Costs and Protecting Their Freedom of Pharmacy Leadership role on a key committee helps to confront “pharmaceutical benefit manipulation” by “PBM” middlemen
Sen. Crapo is leading a press conference in Twin Falls, ID, on addressing PBM practices that have grown increasingly complex and opaque in recent years at the expense of patients and taxpayers.
NACDS Praises Senate Introduction of Bipartisan Legislation Helping to Preserve Medicare Pharmacy Access
NACDS is applauding today the introduction of bipartisan legislation in the U.S. Senate (S. 2477 - the Equitable Community Access to Pharmacist Services Act) that would help maintain the post-pandemic pharmacy access that Americans rely on and expect.
NACDS Lauds Senate Finance Committee for Bipartisan Efforts to Deliver Real and Comprehensive PBM Reform that is Meaningful for Patients and Pharmacies Looks forward to continuing work with leaders in the U.S. Congress to address the “pharmaceutical benefit manipulation” that harms the most vulnerable in the Medicaid and Medicare programs
NACDS looks forward to continuing work with leaders in the U.S. Congress to address the “pharmaceutical benefit manipulation” that harms the most vulnerable in the Medicaid and Medicare programs.
National Coalition Applauds Introduction of Senate Legislation to Ensure Senior Access to Prompt Pharmacist Care and Services More Than 190 Organizations Support S. 2447 to Provide Payment for Pharmacist Services for COVID-19, Flu, Strep, and RSV Under Medicare Part B
More Than 190 Organizations Support S. 2447 to Provide Payment for Pharmacist Services for COVID-19, Flu, Strep, and RSV Under Medicare Part B.
NACDS to the U.S. Congress: Real PBM Reform Must Include Medicare and Medicaid A newly released NACDS video urges this message ahead of a July 26 legislative markup scheduled by the U.S. Senate Committee on Finance
A newly released NACDS video urges this message ahead of a July 26 legislative markup scheduled by the U.S. Senate Committee on Finance.
In Case You Missed It: FTC to PBMs: That Was Then; This is Now
The FTC on Thursday voted, 3-0, “to issue a statement cautioning against reliance on prior advocacy statements and studies related to pharmacy benefit managers (PBM) that no longer reflect current market realities.”
In Case You Missed It: Federal Trade Commission Will Vote on Clarifying That Prior Statements and Studies on PBMs “No Longer Reflect Current Market Realities” FTC: “The statement is a response to PBMs' continued reliance on older FTC advocacy materials”
FTC: “The statement is a response to PBMs' continued reliance on older FTC advocacy materials”
